Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies.
about
Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screeningExploiting the synergy between carboplatin and ABT-737 in the treatment of ovarian carcinomasUpregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathwayClaudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.The overexpression of P21-activated kinase 5 (PAK5) promotes paclitaxel-chemoresistance of epithelial ovarian cancer.Peritoneal carcinosis of ovarian origin.Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.Docetaxel: promising and novel combinations in ovarian cancer.Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancersThe involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers.The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitroATP11B mediates platinum resistance in ovarian cancer.Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells.Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity.Novel strategies for reversing platinum resistance.Effect of FAK, DLC-1 gene expression on OVCAR-3 proliferation.Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells.Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells.DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy.Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy.
P2860
Q28394124-5309BC96-0349-414D-BC8F-2E3F0BF684EDQ28538327-37995955-AF64-40EB-8252-C2E5BE7E7EECQ28539122-6A358AE8-383C-46F3-95F4-B14F2D0F9F4EQ30491616-BF9B72F5-EF2D-4C06-8C98-8E0B6E1BB3BFQ34359273-B39585C2-0956-49A0-9817-B12AB5B99991Q34391112-8C9200A1-2243-4098-B14A-0069122CE880Q35109273-F09E9645-1E56-4B30-BFE1-BBE03F9A558AQ35602190-D5F7068F-C06F-4D45-9EFE-A2EB1DD3B224Q36356952-C8880351-4E3C-4BEC-A39C-407164636E39Q36510122-000D3A0B-EA08-4D46-9204-CAAC07CA5253Q36510142-B75244B5-0CBA-4A4E-92EC-7466DBC9F157Q36793431-66A2B6FB-A393-40C3-86DD-5BDA5D8A5CEEQ37015742-4B2D5633-D65F-4F83-BC11-E490ED1D9A20Q37140728-9302AA19-58FD-4FFA-ACCD-4AEBBC36EC46Q37461061-993ED8AD-3A77-4CFD-AA50-95738567FF66Q39256759-68944178-26C1-48CD-8F41-B9716E49D0C8Q39282673-B4B0E0CE-3004-420E-A3DB-A79B8D5FAF85Q39737951-E1DB3570-B86A-4D1B-A9D4-A83F60D02986Q40235606-DE84CFB5-BA7B-459B-BD05-EEE77C956823Q42364442-4D58C80A-84F4-4987-A88D-DCB3831253B3Q47106467-AB3DD310-03C3-49BF-8E93-4A21E845B20A
P2860
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies.
@ast
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies.
@en
type
label
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies.
@ast
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies.
@en
prefLabel
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies.
@ast
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies.
@en
P2860
P921
P356
P1476
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies.
@en
P2093
P2860
P2888
P356
10.1038/SJ.BJC.6601497
P407
P478
89 Suppl 3
P577
2003-12-01T00:00:00Z